CompletedNot Applicable

Pilot Efficacy Study of the Stendo Pulsating Suit in Patient With Leg Lymphoedema

France25 participantsStarted 2014-09

Plain-language summary

This study aims at evaluating the efficacy of the Stendo pulsating suit in patients with a leg lymphedema hospitalized for intensive Complex Decongestive Physiotherapy (CDP). This study is a pilot controlled randomized study with two arms.

Who can participate

Age range18 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Patient with a primary or secondary lympedema clinically diagnosed (Stemmer Sign) of one or two legs. * Patient with a lympedema stage II (persistent) or III according to the classification of the International Society of Lymphoedema (ISL) * Patient aged 18 or more Exclusion Criteria: * Patient with a severe heart, kidney or liver failure, * Patient with an advanced obstructive arterial disease * Patient with a recent and progressive deep venous thrombosis

What they're measuring

volume of the most affected leg

Timeframe: baseline ; after 5 days intensive CDP

Trial details

NCT IDNCT02234674

SponsorStendo

Sponsor typeINDUSTRY

Study typeINTERVENTIONAL

Primary completion2015-02

View on ClinicalTrials.gov More Primary Lower Limb Lymphedema trials